IP Library › Granted Patent US 9,494,554
Granted Patent B2
US 9,494,554 · App. 13/918,626 · Granted Nov 15, 2016

Chip set-up and high-accuracy nucleic acid sequencing

Inventors: Randall Davis (Pleasanton, CA); Roger Chen (Saratoga, CA); Arkadiusz Bibillo (Cupertino, CA); Kevin Deierling (Pescadero, CA)
Assignee: Genia Technologies, Inc.
G01N27/44791C12Q1/6869G01N33/48721
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,494,554
App. No.
13/918,626
Filed
Jun 14, 2013
Granted
Nov 15, 2016
Kind
B2
Examiner
BALL, JOHN C
Art Unit
1759
USPC
205/775.5
Abstract

The present disclosure provides devices, systems and methods for sequencing nucleic acid molecules. Nucleic acid molecules can be sequenced with a high accuracy (e.g., greater than 97% in a single pass) using a chip comprising an array of independently addressable nanopore sensors at a density of at least about 500 sites per 1 mm 2 . An individual nanopore sensor can include a nanopore in a membrane that is adjacent or in proximity to a sensing electrode.

Claims (33)

1. A device for use in molecular sensing comprising one or more nanopores in a membrane disposed upon at least one membrane incompatible surface in sensing proximity to an electrode coupled to an integrated circuit, wherein said membrane comprising said one or more nanopores exhibits a capacitance greater than about 5 fF/μm2 and a conductance less than about 10 nano Siemens per mole of electrolyte per nanopore as measured by said electrode under an applied voltage of at least about 50 mV.

2. The device of claim 1 , wherein said integrated circuit is an individually addressable integrated circuit.

3. The device of claim 1 , wherein said integrated circuit comprises a logic controller.

4. A method for sequencing a nucleic acid molecule, comprising:

(a) providing a chip comprising an array of sensors, wherein an individual sensor of said array of sensors comprises a membrane adjacent to a sensing electrode, wherein said membrane comprises at least one nanopore configured to aid in the detection of one or more nucleic acid bases of said nucleic acid molecule or portion thereof upon the flow of said nucleic acid molecule or portion thereof through or adjacent to said at least one nanopore;

(b) directing said nucleic acid molecule to said individual sensor;

(c) applying a series of electrical pulses to said membrane upon directing said nucleic acid molecule to said individual sensor; and

(d) detecting one or more nucleic acid bases of said nucleic acid molecule or portion thereof between said series of electrical pulses.

5. A method for sequencing a nucleic acid molecule, comprising:

(a) providing a chip comprising an array of individual sensors, wherein an individual sensor of said array comprises an electrode that is disposed adjacent to a membrane having a nanopore therein, wherein said electrode is coupled to an electrical circuit that is adapted to generate an electrical signal to aid in the detection of said nucleic acid molecule or a portion thereof upon the flow of said nucleic acid molecule or portion thereof through or in proximity to said nanopore;

(b) directing said nucleic acid molecule or portion thereof through or in proximity to said nanopore; and

(c) identifying a nucleic acid sequence of said nucleic acid molecule or portion thereof at an accuracy of at least about 97%.

6. The method of claim 5 , wherein said nucleic acid sequence is generated with the aid of a computer processor coupled to said electrical circuit.

7. The method of claim 5 , wherein said individual sensor is independently addressable.

8. The method of claim 5 , wherein said nucleic acid molecule comprises a tag that is detected by said nanopore upon the incorporation of complementary nucleic acid bases into said nucleic acid molecule.

9. The method of claim 5 , wherein said nucleic acid sequence of said nucleic acid molecule or portion thereof is identified by combining data collected from at least 10 passes of said nucleic acid molecule or portion thereof through or in proximity to said nanopore.

10. The method of claim 9 , wherein said nucleic acid sequence of said nucleic acid molecule or portion thereof is identified by combining data collected from at least 20 passes of said nucleic acid molecule or portion thereof through or in proximity to said nanopore.

11. A system for sequencing a nucleic acid molecule, comprising:

(a) a chip comprising an array of individual sensors, wherein an individual sensor of said array comprises an electrode that is disposed adjacent to a membrane having a nanopore therein, wherein said electrode is coupled to an electrical circuit that is adapted to generate an electrical signal to aid in the detection of said nucleic acid molecule or a portion thereof upon the flow of said nucleic acid molecule or portion thereof through or adjacent to said nanopore; and

(b) a processor coupled to said chip, wherein said processor is programmed to aid in characterizing a nucleic acid sequence of said nucleic acid molecule based on electrical signals received from said plurality of discrete sites at an accuracy of at least about 97%.

12. A system for sensing a biological sample from a subject, the system comprising:

a) a housing;

b) a sensor within the housing, the sensor having an electrical circuit adjacent to a membrane with a nanopore therein, wherein the electrical circuit is adapted to generate an electrical signal in response to the biological sample flowing through or adjacent to the nanopore; and

c) an identification member on or within the housing, the identification member having a unique identifier associated with the system and adapted to aid in associating the electrical signal, or characteristic information derived from the electrical signal, with the subject.

13. A method for manipulating a fluid on a surface, comprising:

(a) providing a surface, an array of electrodes in proximity to the surface, and a fluid comprising a hydrophilic phase and a hydrophobic phase, wherein said hydrophobic phase is adjacent to said surface; and

(b) energizing the electrodes in a spatial and/or temporal pattern, thereby decreasing a volume of said hydrophobic phase in relation to said hydrophilic phase in proximity to said electrodes.

14. A biochip, comprising a nanopore in a membrane that is disposed within, adjacent to, or in proximity to a well, wherein the well comprises an electrode that is capable of detecting a change in the flow of ions through said nanopore in response to a species passing through, in proximity to, or adjacent to the nanopore, wherein said electrode is capable of detecting said change in the flow of ions for at least 1 hour without re-adjusting the ion concentrations on either side of the membrane.

15. A method for forming a biochip, the method comprising:

(a) providing a semiconductor substrate;

(b) forming a plurality of wells in said semiconductor substrate at a density of at least 500 wells/mm2;

(c) forming an electrode in an individual well of said plurality, wherein said electrode is capable of performing electrical measurements of detectable species that are disposed on or adjacent to the semiconductor substrate, and wherein said electrode has an operating life of at least 15 minutes with 40 mV applied potential; and

(d) preparing the substrate for the formation of a membrane that seals the individual well at a resistivity of at least about 10 gigaohms.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE PREVIOUSLY RECORDED AT REEL: 051784 FRAME: 0657. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded Apr 7, 2020
From: GENIA TECHNOLOGIES
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 052331/0880 →
MERGER AND CHANGE OF NAME Recorded Feb 11, 2020
From: GENIA TECHNOLOGIES, INC,; ROCHE SEQUENCING SOLUTIONS, INC,
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 051784/0657 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2014
From: GLENVIEW CAPITAL PARTNERS, L.P.; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD; GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.; GLENVIEW CAPITAL MASTER FUND, LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.
To: GENIA TECHNOLOGIES, INC
Reel/Frame 033083/0203 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2014
From: GLENVIEW CAPITAL PARTNERS, L.P.; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.; GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.; GLENVIEW CAPITAL MASTER FUND, LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.; LIFE TECHNOLOGIES CORPORATION
To: GENIA TECHNOLOGIES, INC
Reel/Frame 033083/0170 →
SECURITY AGREEMENT Recorded Feb 4, 2014
From: GENIA TECHNOLOGIES, INC.
To: GLENVIEW CAPITAL PARTNERS LP; GLENVIEW CAPITAL MASTER FUND LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.; GLENVIEW CAPITAL OPPORTUNITY FUND, LP; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.
Reel/Frame 032161/0007 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: DAVIS, RANDALL; CHEN, ROGER; BIBILLO, ARKADIUSZ; DEIERLING, KEVIN
To: GENIA TECHNOLOGIES, INC.
Reel/Frame 030866/0918 →
Continuity (4)
Provisional Application 61771031 · Feb 28, 2013
Provisional Application 61660537 · Jun 15, 2012
Provisional Application 61660543 · Jun 15, 2012
Related Publication 20140034497A1 · Feb 6, 2014